v3.26.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024   81,850,000      
Beginning balance at Dec. 31, 2024 $ 66,927 $ 8 $ 629,673 $ 52 $ (562,806)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) 339,142 339,000      
Issuance of common stock upon exercise of stock options $ 1,049   1,049    
Issuance of common stock upon release of stock awards (in shares)   669,000      
Issuance of common stock under employee stock purchase plan (in shares)   151,000      
Issuance of common stock under employee stock purchase plan 317   317    
Issuance of common stock in connection with an equity sales agreement, net of issuance costs (in shares)   7,245,000      
Issuance of common stock in connection with an equity sales agreement, net of issuance costs 16,442 $ 1 16,441    
Stock-based compensation 4,911   4,911    
Net loss (33,960)       (33,960)
Other comprehensive loss (55)     (55)  
Ending balance (in shares) at Jun. 30, 2025   90,254,000      
Ending balance at Jun. 30, 2025 55,631 $ 9 652,391 (3) (596,766)
Beginning balance (in shares) at Mar. 31, 2025   82,841,000      
Beginning balance at Mar. 31, 2025 49,629 $ 8 633,101 14 (583,494)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon release of stock awards (in shares)   17,000      
Issuance of common stock under employee stock purchase plan (in shares)   151,000      
Issuance of common stock under employee stock purchase plan 317   317    
Issuance of common stock in connection with an equity sales agreement, net of issuance costs (in shares)   7,245,000      
Issuance of common stock in connection with an equity sales agreement, net of issuance costs 16,442 $ 1 16,441    
Stock-based compensation 2,532   2,532    
Net loss (13,272)       (13,272)
Other comprehensive loss (17)     (17)  
Ending balance (in shares) at Jun. 30, 2025   90,254,000      
Ending balance at Jun. 30, 2025 55,631 $ 9 652,391 (3) (596,766)
Beginning balance (in shares) at Dec. 31, 2025   90,478,000      
Beginning balance at Dec. 31, 2025 $ 50,529 $ 9 657,292 8 (606,780)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) 0        
Issuance of common stock upon release of stock awards (in shares)   813,000      
Issuance of common stock under employee stock purchase plan (in shares)   97,000      
Issuance of common stock under employee stock purchase plan $ 148   148    
Issuance of common stock in connection with an equity sales agreement, net of issuance costs (in shares) 0        
Stock-based compensation $ 3,011   3,011    
Net loss (20,709)       (20,709)
Other comprehensive loss (21)     (21)  
Ending balance (in shares) at Jun. 30, 2026   91,388,000      
Ending balance at Jun. 30, 2026 32,958 $ 9 660,451 (13) (627,489)
Beginning balance (in shares) at Mar. 31, 2026   90,894,000      
Beginning balance at Mar. 31, 2026 43,234 $ 9 658,720 (11) (615,484)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon release of stock awards (in shares)   397,000      
Issuance of common stock under employee stock purchase plan (in shares)   97,000      
Issuance of common stock under employee stock purchase plan 148   148    
Stock-based compensation 1,583   1,583    
Net loss (12,005)       (12,005)
Other comprehensive loss (2)     (2)  
Ending balance (in shares) at Jun. 30, 2026   91,388,000      
Ending balance at Jun. 30, 2026 $ 32,958 $ 9 $ 660,451 $ (13) $ (627,489)